Recent research led by Dr. Joseph H. Dayan, director of the Institute for Lymphatic Surgery and Innovation, suggests that GLP-1 medications like Ozempic and Wegovy may offer hope for lymphedema patients. Dr. Dayan's team has published groundbreaking papers showing these medications can help treat lymphedema and potentially reduce risk in patients undergoing lymph node removal. While emphasizing that this isn't a cure, Dr. Dayan reports encouraging results in multiple patients, with improvements in limb volume, bioimpedance scores, and quality of life. This discovery could offer new options for millions of women affected by this progressive and often misunderstood condition.
Read the complete article here: